行情中心升级到1.1版! 官方博客

基金业绩

基金费率

投资组合

基金概况

财务数据

中欧医疗创新股票A(006228)

2026-11-06     1.5619-3.2400%
持仓重大变化
截止日期:  
 查询其他基金该项数据
序号 股票代码 股票简称 累计买入金额(万元) 占期初净值比例(%)
1002422新华增强债券C58,507.488.22
2002422科伦药业58,507.488.22
3300759康龙化成21,530.923.03
403759康龙化成23,331.043.28
5688506百利天恒39,041.625.49
601276恒瑞医药1,052.580.15
7600276恒瑞医药31,280.914.40
8002294博时新机遇混合C28,465.234.00
9002294信立泰28,465.234.00
10300677英科医疗24,794.733.48
1101877君实生物7,276.411.02
12688180君实生物17,350.682.44
13002821招商丰乐混合A8,111.691.14
14002821凯莱英8,111.691.14
1506821凯莱英16,287.342.29
16002001华夏回报混合A23,987.793.37
17002001新和成23,987.793.37
18002653泰康沪港深精选混合20,438.862.87
19002653海思科20,438.862.87
20301188力诺药包19,493.182.74
2102162康诺亚-B15,964.072.24
2202315百奥赛图-B15,763.402.22
2309926康方生物15,102.712.12
2409995荣昌生物2,259.050.32
25688331荣昌生物12,477.501.75
26301393昊帆生物14,274.712.01
2701530三生制药13,807.381.94
2803696英矽智能13,183.251.85
29002810金信转型创新混合A13,006.531.83
30002810山东赫达13,006.531.83
3101801信达生物12,484.601.75
序号 股票代码 股票简称 累计卖出金额(万元) 占期初净值比例(%)
1603127昭衍新药29,990.734.22
206127昭衍新药10,701.331.50
301530三生制药38,565.035.42
4002294博时新机遇混合C35,249.274.95
5002294信立泰35,249.274.95
601276恒瑞医药1,003.020.14
7600276恒瑞医药24,964.523.51
8300677英科医疗24,131.433.39
9002001华夏回报混合A24,116.563.39
10002001新和成24,116.563.39
11603259药明康德22,176.213.12
1202359药明康德1,760.850.25
1303759康龙化成12,237.621.72
14300759康龙化成10,538.691.48
15002422新华增强债券C22,336.373.14
16002422科伦药业22,336.373.14
1706990科伦博泰生物21,932.093.08
1802269药明生物20,038.522.82
1906821凯莱英8,839.501.24
20002821招商丰乐混合A10,029.231.41
21002821凯莱英10,029.231.41
22002653泰康沪港深精选混合18,343.912.58
23002653海思科18,343.912.58
24688506百利天恒17,435.072.45
25688710益诺思16,750.622.35
26688278特宝生物16,150.282.27
2702268药明合联15,847.892.23
2803347泰格医药5,095.240.72
29300347泰格医药9,666.501.36
3001801信达生物14,156.261.99
3102315百奥赛图-B13,769.721.94
32688796百奥赛图3.720.00